{"ticker": {"uuid": "352ad92c-a187-4af9-b30c-507ada633040", "symbol": "RAC", "name": "Racura Oncology Ltd", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Racura Oncology (ASX:RAC) Edges Higher: Could This ASX Cancer-Therapy Stock Be One to Watch?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTXlXOXQyV2pZNWRJUTRXRFNoaUh5eUhOZm5CUDk4NGRVSnpCZzhaZFZWNjZjMDNKWEF2ZDNaN1I2akxCYmdQU19CeFFESm5zZFJEcWJEY1RYSndJNldncnFVdjh6YW5YeGptNWR6c1VEcFRBcnNBVm1CSEsyQkR3VTJoaEJ4WEhvOWRuY1FaVmlORGpNRXI3QUpIa2FQRWlrTUdTVU56eXFyOVMybGI2cHlQZ2NFOGlTVllEUU5HcENETGI5?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:13:00+00:00", "published_display": "13 Jul 2026 07:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology (ASX:RAC) Draws Investor Interest Amid Recent Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQNGxzNDdLY25ldmxob0hQQUpUOFdYTV8xVmVBajczb0JBbEhZSUZLcXJuazdLX21vWDhYR2MtTktGcWNNb3NUSHNESU5tVHhxOXhVYm9VX2I0SDY2SzFYdDA3Nk96cGI0bWM0YlVfdkhxOHVYQnVzQTBKN1NqNlRWNE5lcm94aUV2UW9jbVVSMzdZZXBtQjgtdFpOd0hXU1E0MUh6OWhtT3l3Q2g2N1hr?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Race Oncology (ASX:RAC): Oncology Stock Commands Huge Market Interest After $34.3m Raising", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTjFpc2ZINFo2NkdpT2dJTlE0SlpWRFhmWGgwQ25UeDNIWVBtaHpQUjFrLWxWdjJVYlp1NkRQMVM2WkhJRWVqbldGT1JHZklIdjBlVGlfdDVzNlFPUkhJejN1dkxoZHl1Tll1enUxaXFDeU43eHk4ODVYdXFESjBuRWlEdnNWOXlTOFZsbFFHeHZOc0ZPMnVTY2JLSHdackstWFpabEp3TzBNN192OVZJcjhTbGJWUnJReDNzZjdOTi0?oc=5", "source_name": "Kalkine", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalkine ASX Spotlight: What Weighed on Race Oncology (ASX:RAC) Shares Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPb1lSUGRzTXZTejdqVDQ0azJablNIeEZ3NE5JM2tIU3l1UTlid0g3SUM1OXRMWjZIRTlqZW5YUUx0YVQxcnR3NkVJM1lCYWtIaW1BeEhydWZlRm0yTjRqcnNTdGNwRWZDdUZIeklxazZjYW9SdmE5a0xKSWZFMzFJVUJPQm1uVnItbXJYR0lTZkw1c0N3eDNXVnNhTWl1aXMzNFp3bVFoeHV5Y2piMURRUjBR?oc=5", "source_name": "Kalkine", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Quotes 526,315 New Ordinary Shares at $1.90 Following Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOTnZuTGRsODh6WUtSUFFjclIyTkU0WW9Gc0F1LUlhdERBOE5RZTZQb3lzcDhwSG5aczMxSkgyUEYyVkRULXFNVWpwVEEtQ2JXQWdRXzNkZDlRUUFWTkRlUnFJeUhyMzJfRmhkblUyZUZYc0ZHTThidkFUZmszWUJMb042eUpXYm84SDEyNDJraWlZZi0ybldaUFYtdVMtZ2dBejN2UWtSN1ltWlNLNmtQdlBNb1ZPaEV2bEE?oc=5", "source_name": "Kalkine", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology (ASX:RAC) Strengthens Funding Position for RC220 Clinical Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNS2t1QkxjbWxoOEdKVk1PaV9KOG1NLTNnN2xMRW5BMl9rSkYxd2hGYm0yOXAtWGFOdDNINnlhQXV2Z3hSbmRnY005dzF6Q19fdGp2X3FIdDlrcFhSbThrSFFWbUFoZm9pSmsxT3otSlF4bWpKT1RBaHpNdnZZMHpsQ3hJU1prU1FWY0loZk5MdE45ZVVZS0tQN0VFaHBTYV9SQlJ2SmczUUx4a0NLd0RKeFNtV3RtYnFx?oc=5", "source_name": "Kalkine", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology (ASX:RAC) Surges 8% as RC220 Trial Cleared to Double Dosage Level", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFBhZTZCOHl6U1pxenJzN3k3X3JpZDZqd2pTOElfcnBLaDB1VnAyQk9vbGFlenFZUWdoUUQ2dzBhTVFXMXljT3Y3SV9td0RwaW1QTXFqSWpZbXJiLUNCMWZFX2tJck1PaTh3TlNlbzlfWWtfWHpzOEE?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Racura Oncology (ASX:RAC) Be on Your Watchlist?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPS2FTWDl2UjM2SHFpVmtCeEpMSjF2NjU0UW1kNzBwNEhsbEJlSTVwQWtVRlBNcVR4MHhYM0FKRkhIODhVQVUwdmdzUXFSalo2MktCaG92Q2JmZ0JzQU1ld0hfbVV6VkFJVW15TWtYUjl2dVFDZnhCakRUQVJ0di1IUUhja25rdG5LMXNZUHlPTHg5RGc?oc=5", "source_name": "Kalkine", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Shortz with Racura: Tackling MYC-driven cancer pathways", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology: Lung Cancer trial targets resistance - ASX SMIDcaps Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOFZqdjFyYml2V2F0TEdBck9nS3I3UTd4MVpvSHRhMDZ4T0pRc1g1VTFaY2ZBcE91MTlRX3hLY1pBMnNDUm1NQjF2S0tCd3E3ODZUakF1ZlN0SFY5dXJ3Y1RvM0hZdkV1NjEtX0dhUXcyYXVkRVFvWlg4UjFHQjdEVGNtbWYtdHhGVUVJRGVOZUNhRGg5WmJzczdJajRtakdJU0NxOU9ZNGNaRER6MnQxZ1BmaHB1ajM2NnRCQWRtQTVTYmcwdHJxN3lJTEx1VS1HOUFnY1VhLXJWZw?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura hits CPACS trial milestone", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Shares Move Positive YTD on RC220 Milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQT3ZEV2ZsZ3dqVEMwNEJMbENYVzdqUGpVSjltb19sYTcyUUg0d3hXbFdCOGd1ckNOTjYzbk9FbzRVbXVxanQ3anZpYmpiR1ZtWHJYLVdQd3NJUl9IU2xHY2NoVGRBYW9mTXZYWEhmcmtuXzlycW5QM21tQjZHR1JiZHNfVkdZRG13RkZfcjBxV243QQ?oc=5", "source_name": "thebull.com.au", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Racura Oncology (ASX:RAC) Stock Is Surging 10% Today: Cancer Drug Catalysts Driving Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRGNaS2hYbjM2aTIxN1VZbk5tV2lhZXpQb0R0QXlTM1FyN0pMbnZSRnpndEJ4UXJCZ0xSYTFmS3IwVm9uc0lBU2plU19MbzFoUER1c1l2TGpxNlBBZGE3VU9ETDZvcFN6Z2pFclY3cWprMkxrdkp3NHRTNDhFeXBhdGZBYkwwY2hfcVNZMGpHMzM3SXJvRGRLRDU4azY5ZWktajNqNHcyVjMydmVQUjZ5Z181dlhWMUlYekhPanAxWlZTZ1c0dFk0QQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura receives governance approval for trial.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "The Australian", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2026: The road ahead with Racura Oncology", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura secures $3.2M for lung cancer trial - ICYMI", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOLTJaSlZNRnFYZG1BMXV5WU1jVmhUVGxNOGlnWUpsS3RLYldHdGYwcUJaaGk5SmZ3U3hRS1lVR2JRdUJLWWo0MjFpbVBXS0JOWm1Zbi1MQkZMRjRPZUJoalZyWDEtWHpOVTQ2eGNfeFlIMUlkWlFMUEhvVzFqX1gxcEZKYVdEUTQ5ZE1FcUFERmlsVUJ0UnI4aEY4TTE1c0FLeTdrX1pDRm9XTWVUQVdZeXJ6VTU2em9VSm5qX09B?oc=5", "source_name": "Proactive financial news", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Race Oncology changes name to Racura Oncology as HARNESS-1 trial gains momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTXB6QmxrWFdYS0pQVERKa3dQdjBIVTB0RzBQUTc3VWRQWVdsQjlqMGVXbl9aMzNhaEs0RGlZMl9jSlhRSVVSR3pTX0JlNTdqQ19mVVBJbDI1N015S29QV2hsdG1Hb1FaakNodklfdzRzczNNbDZGaFYyX3hsUUhhMWpDSERSSmxMRng5UjIwR1hzb3AxQ3BlNWlyTkgxQ242QVZVbjlXaVhybVZyb1ZldVZ6U3pLRDM3cGZnZ0IyU0tHbFR1cTQ3dk5hZmRKYmNiOFVOeXdUYUQwM3Nfb1FoWDdnRlZ6SHdv?oc=5", "source_name": "Proactive financial news", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX:RAC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1yckJmZTMyRUZfZ3F4aWM0aFE3TzhDSm5sTWNuRGg1TGFPZy1FYUdjcDBBb2daUzl2M3BpdkJWMDMxVEJBSVkzTEFmaWJkTTNoeWVsQUwwSXlTYkpUQTZLT1g1RkJHaGxQNkRZZFV4ZEFCdndXUlZmZHV2V1FUUQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-12-09T11:14:04+00:00", "published_display": "09 Dec 2025 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX: RAC) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPSENJSFhXeE0yWm1vV1BocnJHdTQtaVBLZDY2SXZMTmpJaXlmYmpCbHliOW0xV1pUVFBvYmp2eUhNX3g1Sl9pdDc5bzBCVU5OVjZxeFRGVGJueFBxV0NSMjcwX1lIMTJvemtTVUlaUVd0Rk9lS2JsNWJ0Y2ZFZWFFRDZGQi1oaGprb3duX3pR?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-12-09T11:14:03+00:00", "published_display": "09 Dec 2025 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFB4eWFXal9ZU0ZrQUxBa1NRRGVpNEdoTzRST2dzWXZBOG5zaTNzYm5pNHp5cU9jX0NaOTZfREh5dlRPMlVZVEw2V0hWekdackNxRGpBZGhOOVlVdmRDTEQtdElJMlFKUXFQMFRCbFJzQzdEaWNndWJnWmROX3NKWm8?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Race Oncology's (ASX:RAC) New Bisantrene Patents a Turning Point for Its Competitive Edge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-21T07:00:00+00:00", "published_display": "21 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX: RAC) - Dividends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxON182OEd5YXZPeU9FRzZWNWZJWnBacWlHUmF5NkhYZ05JVllBU0tjcUhfdG94UDZOdmpwcloyV2owclZ4NElLd0RRaDRmOVpGaGZpSE12aXFuWERoSC1PTVlUV3VmLXZDOTlZelg5Y3NMNXpHeUFZVHNLWUwyZm1KbTRvUHZ0cGVW?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-10-03T10:55:21+00:00", "published_display": "03 Oct 2019 10:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX: RAC) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQemFTZ29USm9FU1BxVDBSajN5NGVLR0tFNmlscG10NzJyRmV1cGJoeng2Z01TeURnSWVNaGFHTDRlU05yYlZwSHpZTS16a2NtbzlyVUtyaFpGY2xZNGoxLVQxUC1Sa3JQZG5jT2JDYjRnMlhybEV2ZThyTlR0SXFWOUV1ZGt3UG1LSllISDZR?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-30T15:39:57+00:00", "published_display": "30 Sep 2019 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RAC Stock Price and Chart \u2014 ASX:RAC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9lVV8tRW4wSnRaRjduTDRpZ1o3ZTFnYkdDeWdwQkRrc0E2Wm5tV3MwbFhHOHNYeGxRdS1yNGkyNDgwdjQ2VDdsM25Ya3lzMjJYYW9uSFhIRQ?oc=5", "source_name": "TradingView", "published_at": "2017-08-02T11:35:22+00:00", "published_display": "02 Aug 2017 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Racura Oncology (ASX:RAC) Edges Higher: Could This ASX Cancer-Therapy Stock Be One to Watch?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTXlXOXQyV2pZNWRJUTRXRFNoaUh5eUhOZm5CUDk4NGRVSnpCZzhaZFZWNjZjMDNKWEF2ZDNaN1I2akxCYmdQU19CeFFESm5zZFJEcWJEY1RYSndJNldncnFVdjh6YW5YeGptNWR6c1VEcFRBcnNBVm1CSEsyQkR3VTJoaEJ4WEhvOWRuY1FaVmlORGpNRXI3QUpIa2FQRWlrTUdTVU56eXFyOVMybGI2cHlQZ2NFOGlTVllEUU5HcENETGI5?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:13:00+00:00", "published_display": "13 Jul 2026 07:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology (ASX:RAC) Draws Investor Interest Amid Recent Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQNGxzNDdLY25ldmxob0hQQUpUOFdYTV8xVmVBajczb0JBbEhZSUZLcXJuazdLX21vWDhYR2MtTktGcWNNb3NUSHNESU5tVHhxOXhVYm9VX2I0SDY2SzFYdDA3Nk96cGI0bWM0YlVfdkhxOHVYQnVzQTBKN1NqNlRWNE5lcm94aUV2UW9jbVVSMzdZZXBtQjgtdFpOd0hXU1E0MUh6OWhtT3l3Q2g2N1hr?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Race Oncology (ASX:RAC): Oncology Stock Commands Huge Market Interest After $34.3m Raising", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTjFpc2ZINFo2NkdpT2dJTlE0SlpWRFhmWGgwQ25UeDNIWVBtaHpQUjFrLWxWdjJVYlp1NkRQMVM2WkhJRWVqbldGT1JHZklIdjBlVGlfdDVzNlFPUkhJejN1dkxoZHl1Tll1enUxaXFDeU43eHk4ODVYdXFESjBuRWlEdnNWOXlTOFZsbFFHeHZOc0ZPMnVTY2JLSHdackstWFpabEp3TzBNN192OVZJcjhTbGJWUnJReDNzZjdOTi0?oc=5", "source_name": "Kalkine", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kalkine ASX Spotlight: What Weighed on Race Oncology (ASX:RAC) Shares Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPb1lSUGRzTXZTejdqVDQ0azJablNIeEZ3NE5JM2tIU3l1UTlid0g3SUM1OXRMWjZIRTlqZW5YUUx0YVQxcnR3NkVJM1lCYWtIaW1BeEhydWZlRm0yTjRqcnNTdGNwRWZDdUZIeklxazZjYW9SdmE5a0xKSWZFMzFJVUJPQm1uVnItbXJYR0lTZkw1c0N3eDNXVnNhTWl1aXMzNFp3bVFoeHV5Y2piMURRUjBR?oc=5", "source_name": "Kalkine", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Quotes 526,315 New Ordinary Shares at $1.90 Following Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOTnZuTGRsODh6WUtSUFFjclIyTkU0WW9Gc0F1LUlhdERBOE5RZTZQb3lzcDhwSG5aczMxSkgyUEYyVkRULXFNVWpwVEEtQ2JXQWdRXzNkZDlRUUFWTkRlUnFJeUhyMzJfRmhkblUyZUZYc0ZHTThidkFUZmszWUJMb042eUpXYm84SDEyNDJraWlZZi0ybldaUFYtdVMtZ2dBejN2UWtSN1ltWlNLNmtQdlBNb1ZPaEV2bEE?oc=5", "source_name": "Kalkine", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology (ASX:RAC) Strengthens Funding Position for RC220 Clinical Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNS2t1QkxjbWxoOEdKVk1PaV9KOG1NLTNnN2xMRW5BMl9rSkYxd2hGYm0yOXAtWGFOdDNINnlhQXV2Z3hSbmRnY005dzF6Q19fdGp2X3FIdDlrcFhSbThrSFFWbUFoZm9pSmsxT3otSlF4bWpKT1RBaHpNdnZZMHpsQ3hJU1prU1FWY0loZk5MdE45ZVVZS0tQN0VFaHBTYV9SQlJ2SmczUUx4a0NLd0RKeFNtV3RtYnFx?oc=5", "source_name": "Kalkine", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology (ASX:RAC) Surges 8% as RC220 Trial Cleared to Double Dosage Level", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTFBhZTZCOHl6U1pxenJzN3k3X3JpZDZqd2pTOElfcnBLaDB1VnAyQk9vbGFlenFZUWdoUUQ2dzBhTVFXMXljT3Y3SV9td0RwaW1QTXFqSWpZbXJiLUNCMWZFX2tJck1PaTh3TlNlbzlfWWtfWHpzOEE?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Racura Oncology (ASX:RAC) Be on Your Watchlist?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPS2FTWDl2UjM2SHFpVmtCeEpMSjF2NjU0UW1kNzBwNEhsbEJlSTVwQWtVRlBNcVR4MHhYM0FKRkhIODhVQVUwdmdzUXFSalo2MktCaG92Q2JmZ0JzQU1ld0hfbVV6VkFJVW15TWtYUjl2dVFDZnhCakRUQVJ0di1IUUhja25rdG5LMXNZUHlPTHg5RGc?oc=5", "source_name": "Kalkine", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Shortz with Racura: Tackling MYC-driven cancer pathways", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology: Lung Cancer trial targets resistance - ASX SMIDcaps Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOFZqdjFyYml2V2F0TEdBck9nS3I3UTd4MVpvSHRhMDZ4T0pRc1g1VTFaY2ZBcE91MTlRX3hLY1pBMnNDUm1NQjF2S0tCd3E3ODZUakF1ZlN0SFY5dXJ3Y1RvM0hZdkV1NjEtX0dhUXcyYXVkRVFvWlg4UjFHQjdEVGNtbWYtdHhGVUVJRGVOZUNhRGg5WmJzczdJajRtakdJU0NxOU9ZNGNaRER6MnQxZ1BmaHB1ajM2NnRCQWRtQTVTYmcwdHJxN3lJTEx1VS1HOUFnY1VhLXJWZw?oc=5", "source_name": "Proactive financial news", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura hits CPACS trial milestone", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Shares Move Positive YTD on RC220 Milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQT3ZEV2ZsZ3dqVEMwNEJMbENYVzdqUGpVSjltb19sYTcyUUg0d3hXbFdCOGd1ckNOTjYzbk9FbzRVbXVxanQ3anZpYmpiR1ZtWHJYLVdQd3NJUl9IU2xHY2NoVGRBYW9mTXZYWEhmcmtuXzlycW5QM21tQjZHR1JiZHNfVkdZRG13RkZfcjBxV243QQ?oc=5", "source_name": "thebull.com.au", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Racura Oncology (ASX:RAC) Stock Is Surging 10% Today: Cancer Drug Catalysts Driving Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRGNaS2hYbjM2aTIxN1VZbk5tV2lhZXpQb0R0QXlTM1FyN0pMbnZSRnpndEJ4UXJCZ0xSYTFmS3IwVm9uc0lBU2plU19MbzFoUER1c1l2TGpxNlBBZGE3VU9ETDZvcFN6Z2pFclY3cWprMkxrdkp3NHRTNDhFeXBhdGZBYkwwY2hfcVNZMGpHMzM3SXJvRGRLRDU4azY5ZWktajNqNHcyVjMydmVQUjZ5Z181dlhWMUlYekhPanAxWlZTZ1c0dFk0QQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura receives governance approval for trial.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "The Australian", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2026: The road ahead with Racura Oncology", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura secures $3.2M for lung cancer trial - ICYMI", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOLTJaSlZNRnFYZG1BMXV5WU1jVmhUVGxNOGlnWUpsS3RLYldHdGYwcUJaaGk5SmZ3U3hRS1lVR2JRdUJLWWo0MjFpbVBXS0JOWm1Zbi1MQkZMRjRPZUJoalZyWDEtWHpOVTQ2eGNfeFlIMUlkWlFMUEhvVzFqX1gxcEZKYVdEUTQ5ZE1FcUFERmlsVUJ0UnI4aEY4TTE1c0FLeTdrX1pDRm9XTWVUQVdZeXJ6VTU2em9VSm5qX09B?oc=5", "source_name": "Proactive financial news", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Race Oncology changes name to Racura Oncology as HARNESS-1 trial gains momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTXB6QmxrWFdYS0pQVERKa3dQdjBIVTB0RzBQUTc3VWRQWVdsQjlqMGVXbl9aMzNhaEs0RGlZMl9jSlhRSVVSR3pTX0JlNTdqQ19mVVBJbDI1N015S29QV2hsdG1Hb1FaakNodklfdzRzczNNbDZGaFYyX3hsUUhhMWpDSERSSmxMRng5UjIwR1hzb3AxQ3BlNWlyTkgxQ242QVZVbjlXaVhybVZyb1ZldVZ6U3pLRDM3cGZnZ0IyU0tHbFR1cTQ3dk5hZmRKYmNiOFVOeXdUYUQwM3Nfb1FoWDdnRlZ6SHdv?oc=5", "source_name": "Proactive financial news", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX:RAC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1yckJmZTMyRUZfZ3F4aWM0aFE3TzhDSm5sTWNuRGg1TGFPZy1FYUdjcDBBb2daUzl2M3BpdkJWMDMxVEJBSVkzTEFmaWJkTTNoeWVsQUwwSXlTYkpUQTZLT1g1RkJHaGxQNkRZZFV4ZEFCdndXUlZmZHV2V1FUUQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-12-09T11:14:04+00:00", "published_display": "09 Dec 2025 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX: RAC) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPSENJSFhXeE0yWm1vV1BocnJHdTQtaVBLZDY2SXZMTmpJaXlmYmpCbHliOW0xV1pUVFBvYmp2eUhNX3g1Sl9pdDc5bzBCVU5OVjZxeFRGVGJueFBxV0NSMjcwX1lIMTJvemtTVUlaUVd0Rk9lS2JsNWJ0Y2ZFZWFFRDZGQi1oaGprb3duX3pR?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-12-09T11:14:03+00:00", "published_display": "09 Dec 2025 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFB4eWFXal9ZU0ZrQUxBa1NRRGVpNEdoTzRST2dzWXZBOG5zaTNzYm5pNHp5cU9jX0NaOTZfREh5dlRPMlVZVEw2V0hWekdackNxRGpBZGhOOVlVdmRDTEQtdElJMlFKUXFQMFRCbFJzQzdEaWNndWJnWmROX3NKWm8?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Race Oncology's (ASX:RAC) New Bisantrene Patents a Turning Point for Its Competitive Edge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-21T07:00:00+00:00", "published_display": "21 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX: RAC) - Dividends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxON182OEd5YXZPeU9FRzZWNWZJWnBacWlHUmF5NkhYZ05JVllBU0tjcUhfdG94UDZOdmpwcloyV2owclZ4NElLd0RRaDRmOVpGaGZpSE12aXFuWERoSC1PTVlUV3VmLXZDOTlZelg5Y3NMNXpHeUFZVHNLWUwyZm1KbTRvUHZ0cGVW?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-10-03T10:55:21+00:00", "published_display": "03 Oct 2019 10:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Racura Oncology Ltd (ASX: RAC) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQemFTZ29USm9FU1BxVDBSajN5NGVLR0tFNmlscG10NzJyRmV1cGJoeng2Z01TeURnSWVNaGFHTDRlU05yYlZwSHpZTS16a2NtbzlyVUtyaFpGY2xZNGoxLVQxUC1Sa3JQZG5jT2JDYjRnMlhybEV2ZThyTlR0SXFWOUV1ZGt3UG1LSllISDZR?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-30T15:39:57+00:00", "published_display": "30 Sep 2019 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RAC Stock Price and Chart \u2014 ASX:RAC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9lVV8tRW4wSnRaRjduTDRpZ1o3ZTFnYkdDeWdwQkRrc0E2Wm5tV3MwbFhHOHNYeGxRdS1yNGkyNDgwdjQ2VDdsM25Ya3lzMjJYYW9uSFhIRQ?oc=5", "source_name": "TradingView", "published_at": "2017-08-02T11:35:22+00:00", "published_display": "02 Aug 2017 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 87, "total_relevant": 24, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 20, "score": 53, "total": 24, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 12.1, "count": 22}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.19, "latest_week": "2026-07-10", "one_week_move": -4.4, "four_week_move": -8.8, "twelve_week_move": -30.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.030068, "market_dynamics_buy_signal": false, "relative_strength": -13.915618, "fair_value_gap": 30.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.1333, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.4% over one week, -8.8% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 8}, {"label": "The Australian", "count": 4}, {"label": "intelligentinvestor.com.au", "count": 4}, {"label": "Proactive financial news", "count": 3}, {"label": "Stocks Down Under", "count": 1}, {"label": "thebull.com.au", "count": 1}, {"label": "Market source", "count": 1}, {"label": "simplywall.st", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 24}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Regulatory and legal", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "24", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.4% over one week, -8.8% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Racura Oncology (ASX:RAC) Edges Higher: Could This ASX Cancer-Therapy Stock Be One to Watch?"}], "updated_at": "2026-07-17T08:44:13.084560+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}